Angiocrine extracellular vesicles impose mesenchymal reprogramming upon proneural glioma stem cells

被引:0
|
作者
Lata Adnani
Jordan Kassouf
Brian Meehan
Cristiana Spinelli
Nadim Tawil
Ichiro Nakano
Janusz Rak
机构
[1] Research Institute of the McGill University Health Centre,Department of Biochemistry
[2] McGill University,Department of Neurosurgery, Hokuto Social Medical Corporation
[3] Hokuto Hospital,Department of Pediatrics
[4] McGill University,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Glioblastoma (GBM) is an incurable form of primary astrocytic brain tumor driven by glioma stem cell (GSC) compartment closely associated with the vascular niche. GSC phenotypes are heterogeneous and range from proneural to mesenchymal-like, the latter characterised by greater invasiveness. Here we document the secretory (angiocrine) role of endothelial cells and their derived extracellular vesicles (EVs) as drivers of proneural-to-mesenchymal reprogramming of GSCs. These changes involve activation of matrix metalloproteinases (MMPs) and NFκB, and inactivation of NOTCH, while altering responsiveness to chemotherapy and driving infiltrative growth in the brain. Our findings suggest that EV-mediated angiocrine interactions impact the nature of cellular stemness in GBM with implications for disease biology and therapy.
引用
收藏
相关论文
共 50 条
  • [31] Generation of mesenchymal stem-like cells for producing extracellular vesicles
    Kim, Soo
    Kim, Tae Min
    WORLD JOURNAL OF STEM CELLS, 2019, 11 (05): : 270 - 280
  • [32] Therapeutic Application of Mesenchymal Stem Cells Derived Extracellular Vesicles for Immunomodulation
    Gomzikova, Marina O.
    James, Victoria
    Rizvanov, Albert A.
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [33] Mesenchymal stem cells and extracellular vesicles in therapy against kidney diseases
    Huang, Yuling
    Yang, Lina
    STEM CELL RESEARCH & THERAPY, 2021, 12 (01)
  • [34] Immunosuppressive properties of cytochalasin B-induced membrane vesicles of mesenchymal stem cells: comparing with extracellular vesicles derived from mesenchymal stem cells
    Gomzikova, M. O.
    Aimaletdinov, A. M.
    Bondar, O. V.
    Starostina, I. G.
    Gorshkova, N. V.
    Neustroeva, O. A.
    Kletukhina, S. K.
    Kurbangaleeva, S. V.
    Vorobev, V. V.
    Garanina, E. E.
    Persson, J. L.
    Jeyapalan, J.
    Mongan, N. P.
    Khaiboullina, S. F.
    Rizvanov, A. A.
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [35] Immunosuppressive properties of cytochalasin B-induced membrane vesicles of mesenchymal stem cells: comparing with extracellular vesicles derived from mesenchymal stem cells
    M. O. Gomzikova
    A. M. Aimaletdinov
    O. V. Bondar
    I. G. Starostina
    N. V. Gorshkova
    O. A. Neustroeva
    S. K. Kletukhina
    S. V. Kurbangaleeva
    V. V. Vorobev
    E. E. Garanina
    J. L. Persson
    J. Jeyapalan
    N. P. Mongan
    S. F. Khaiboullina
    A. A. Rizvanov
    Scientific Reports, 10
  • [36] Extracellular vesicles of mesenchymal cells in culture
    Luis Paino, C.
    Casado, S.
    HUMAN GENE THERAPY, 2013, 24 (12) : A69 - A70
  • [37] Immunomodulatory Effects of Mesenchymal Stem Cells and Mesenchymal Stem Cell-Derived Extracellular Vesicles in Rheumatoid Arthritis
    Liu, Huan
    Li, Ruicen
    Liu, Tao
    Yang, Leiyi
    Yin, Geng
    Xie, Qibing
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [38] Mesenchymal stem cells and mesenchymal stem cell-derived extracellular vesicles: Potential roles in rheumatic diseases
    Yang, Jing-Han
    Liu, Feng-Xia
    Wang, Jing-Hua
    Cheng, Min
    Wang, Shu-Feng
    Xu, Dong-Hua
    WORLD JOURNAL OF STEM CELLS, 2020, 12 (07): : 688 - 705
  • [39] Reprogramming of mesenchymal stem cells by oncogenes
    Eid, Josiane E.
    Garcia, Christina B.
    SEMINARS IN CANCER BIOLOGY, 2015, 32 : 18 - 31
  • [40] Epigenetic Reprogramming of Mesenchymal Stem Cells
    Leu, Yu-Wei
    Huang, Tim H. -M.
    Hsiao, Shu-Huei
    EPIGENETIC ALTERATIONS IN ONCOGENESIS, 2013, 754 : 195 - 211